Richard Jones II's Colleagues at QED Therapeutics
Richard Jones II's Contact Details
HQ
650-231-4088
650-231-4088
Location
Morgantown, West Virginia, United States
Morgantown, West Virginia, United States
Company
QED Therapeutics
QED Therapeutics
Richard Jones II's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Richard Jones II
Richard Jones II currently works for QED Therapeutics.
Richard Jones II's role at QED Therapeutics is Associate Director of Quality Assurance.
Richard Jones II's email address is ***@qedtx.com. To view Richard Jones II's full email address, please signup to ConnectPlex.
Richard Jones II works in the BioTech/Drugs industry.
Richard Jones II's colleagues at QED Therapeutics are Edward Oliva, Sudesh PhD, Quoc M., Ai Li, Craig Berman, Elena Muslimova, Dan Mulreany and others.
Richard Jones II's phone number is 650-231-4088